EFFECTIVENESS OF LIMOSILACTOBACILLUS REUTERI IN THE PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS: A RANDOMIZED PLACEBO-CONTROLLED SINGLE-CENTER CLINICAL TRIAL

被引:0
|
作者
Gregori, G. [1 ]
Pivodic, A. [2 ]
Magnusson, P. [3 ]
Johansson, L. [4 ]
Hjertonsson, U. [1 ]
Brattemark, E. [1 ]
Lorentzon, M. [1 ]
机构
[1] Univ Gothenburg, Dept Internal Med & Clin Nutr, Sahlgrenska Osteoporosis Ctr, Gothenburg, Sweden
[2] APNC, Gothenburg, Sweden
[3] Univ Linkoping, Dept Clin Chem Biomed & Clin Sci, Linkoping, Sweden
[4] Sahlgrenska Univ, Hosp Vastra Gotland Reg, Dept Orthoped, Molndal, Sweden
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
P526
引用
收藏
页码:S280 / S280
页数:1
相关论文
共 50 条
  • [21] Evidence of cancer prevention by selenium in a randomized, placebo-controlled, clinical trial
    Combs, GF
    Clark, LC
    Turnbull, BW
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 5, 1998, 5 : 566 - 571
  • [22] 1-YEAR CONTROLLED RANDOMIZED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN
    REGINSTER, JY
    ALBERT, A
    LECART, MP
    LAMBELIN, P
    DENIS, D
    DEROISY, R
    FONTAINE, MA
    FRANCHIMONT, P
    LANCET, 1987, 2 (8574): : 1481 - 1483
  • [23] Impact of extracorporeal shockwave therapy on tooth mobility in adult orthodontic patients: a randomized single-center placebo-controlled clinical trial
    Falkensammer, Frank
    Rausch-Fan, Xiaohui
    Schaden, Wolfgang
    Kivaranovic, Danijel
    Freudenthaler, Josef
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2015, 42 (03) : 294 - 301
  • [24] Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial
    Kasgari, Hamideh Abbaspour
    Moradi, Siavosh
    Alikhani, Ahmad
    Ahmadian, Nasim
    BIOIMPACTS, 2024,
  • [25] Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
    Fatheree, Nicole Y.
    Liu, Yuying
    Taylor, Christopher M.
    Hoang, Thomas K.
    Cai, Chunyan
    Rahbar, Mohammad H.
    Hessabi, Manouchehr
    Ferris, Michael
    McMurtry, Valarie
    Wong, Christine
    Ta Vu
    Dancsak, Theresa
    Wang, Ting
    Gleason, Wallace
    Bandla, Vinay
    Navarro, Fernando
    Tran, Dat Q.
    Rhoads, J. Marc
    JOURNAL OF PEDIATRICS, 2017, 191 : 170 - +
  • [26] Prevention of early postmenopausal bone loss by strontium ranelate: A randomised, two-year, double-blind, placebo-controlled trial.
    Reginster, JL
    Deroisy, R
    Tsouderos, Y
    Jupsin, I
    Roux, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S222 - S222
  • [27] Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy - a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial
    Biernacka-Fialkowska, Barbara
    Szuksztul, Marta
    Suslik, Wojciech
    Dzierwa, Karolina
    Tekieli, Lukasz
    Kostkiewicz, Magdalena
    Podolec, Piotr
    Pieniazek, Piotr
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2018, 14 (01): : 59 - 66
  • [28] The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial
    Benjawan, Saksit
    Nimitphong, Hataikarn
    Tragulpiankit, Pramote
    Musigavong, Olarik
    Prathanturarug, Sompop
    Pathomwichaiwat, Thanika
    PHYTOMEDICINE, 2022, 101
  • [29] NASAL SALMON-CALCITONIN FOR PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS - A DOSE-RANGING PLACEBO-CONTROLLED STUDY
    REGINSTER, JY
    DEROISY, R
    LECART, MP
    ZEGELS, B
    SARLET, N
    DELONGUEVILLE, M
    ALBERT, A
    FRANCHIMONT, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S340 - S340
  • [30] Zoledronic acid for the treatment of osteoporosis in patients with β-thalassemia: results from a single-center, randomized, placebo-controlled trial
    Voskaridou, Ersi
    Anagnostopoulos, Athanasios
    Konstantopoulos, Kostas
    Stoupa, Eleni
    Spyropoulou, Evgenia
    Kiamouris, Christos
    Terpos, Evangelos
    HAEMATOLOGICA, 2006, 91 (09) : 1193 - 1202